HomeInsightsStock Comparison

Gujarat Terce Laboratories Ltd vs Parmax Pharma Ltd Stock Comparison

Gujarat Terce Laboratories Ltd vs Parmax Pharma Ltd Stock Comparison

Last Updated on: Jun 04, 2025

Key Highlights

  • The Latest Trading Price of Gujarat Terce Laboratories Ltd is ₹ 54.97 as of 04 Jun 15:30.
  • The P/E Ratio of Gujarat Terce Laboratories Ltd changed from 17.1 on March 2020 to 160.4 on March 2024 . This represents a CAGR of 56.47% over 5 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Market Cap of Gujarat Terce Laboratories Ltd changed from ₹ 4.7 crore on March 2020 to ₹ 39.29 crore on March 2024 . This represents a CAGR of 52.91% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 10.66 crore on March 2024 . This represents a CAGR of -5.35% over 4 years.
  • The revenue of Gujarat Terce Laboratories Ltd for the Mar '25 is ₹ 12.41 crore as compare to the Dec '24 revenue of ₹ 12.75 crore. This represent the decline of -2.67% The revenue of Parmax Pharma Ltd for the Mar '25 is ₹ 4.73 crore as compare to the Dec '24 revenue of ₹ 6.3 crore. This represent the decline of -24.92%.
  • The ebitda of Gujarat Terce Laboratories Ltd for the Mar '25 is ₹ 1.14 crore as compare to the Dec '24 ebitda of ₹ 1.16 crore. This represent the decline of -1.72% The ebitda of Parmax Pharma Ltd for the Mar '25 is ₹ -1.74 crore as compare to the Dec '24 ebitda of ₹ 0.12 crore. This represent the decline of -1550%.
  • The net profit of Gujarat Terce Laboratories Ltd changed from ₹ -1.31 crore to ₹ -3.39 crore over 8 quarters. This represents a CAGR of 60.87% The net profit of Parmax Pharma Ltd changed from ₹ -1.18 crore to ₹ -1.49 crore over 8 quarters. This represents a CAGR of 12.37% .
  • The Dividend Payout of Gujarat Terce Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gujarat Terce Laboratories Ltd

  • Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market.
  • Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states.
  • Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing.
  • In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange.
  • In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat.

About Parmax Pharma Ltd

  • Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
  • The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
  • The Company then discontinued their business activities for few years due to various reasons.
  • Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

Gujarat Terce Laboratories Ltd News Hub

News

Gujarat Terce Laboratories to discuss results

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

20 May 2025 16:53

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

27 Jan 2025 14:03

News

Gujarat Terce Laboratories to declare Quarterly Result

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

18 Oct 2024 17:17

News

Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting (AGM) of the company ...

Read more

20 Aug 2024 16:03

News

Gujarat Terce Laboratories to conduct board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

03 Aug 2024 17:01

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

22 May 2024 14:31

Parmax Pharma Ltd News Hub

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 30 May 2025....

Read more

22 May 2025 19:45

News

Parmax Pharma to conduct board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

07 Feb 2025 15:55

News

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

07 Nov 2024 11:45

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 2024 16:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 2024 14:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 2024 12:10

SWOT Analysis Of Gujarat Terce Laboratories Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Parmax Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gujarat Terce Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Gujarat Terce Laboratories Ltd or Parmax Pharma Ltd?

Market cap of Gujarat Terce Laboratories Ltd is 40 Cr while Market cap of Parmax Pharma Ltd is 15 Cr

What are the key factors driving the stock performance of Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd?

The stock performance of Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd?

As of June 4, 2025, the Gujarat Terce Laboratories Ltd stock price is INR ₹54.97. On the other hand, Parmax Pharma Ltd stock price is INR ₹41.7.

How do dividend payouts of Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Gujarat Terce Laboratories Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions